Reports on the approval for marketing gained by topotecan, a drug for the treatment of advanced, recurrent ovarian cancer. Pivotal role of topotecan described by James Carmichael at the meeting of the American Society of Clinical Oncology; Aim to develop a form of topotecan that could be given orally.